hydroxyproline has been researched along with Autoimmune Diabetes in 18 studies
Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydroxyproline excretion was increased in both types of diabetes: Type 1: 21 (10-36) (median (IQR) mumol mmol creatinine-1; Type 2: 25 (13-43) mumol mmol creatinine-1; control: 10 (6-22) mumol mmol creatinine-1 (p < 0." | 5.29 | Hydroxyproline excretion is increased in diabetes mellitus and related to the presence of microalbuminuria. ( Marshall, SM; Selby, PL; Shearing, PA, 1995) |
| "We observed that BMD in IDDM patients before 40 years old was significantly lower than in healthy subject." | 2.68 | [Bone mineralization in insulin-dependent diabetes mellitus]. ( Goliat, E; Lipińska, A; Marusza, W; Ostrowski, K, 1997) |
| "The hydroxyproline level was determined by means of high-performance liquid chromatography; the collagenase activity, by using a radiolabeled collagen substrate." | 1.32 | Decrease of collagen deposition in wound repair in type 1 diabetes independent of glycemic control. ( Agren, MS; Black, E; Gottrup, F; Holstein, PE; Jorgensen, LN; Madsen, SM; Perrild, H; Vibe-Petersen, J, 2003) |
| "We examined 60 IDDM patients (30 women without menstruation disturbances; 30 men; age 25-36 years old)." | 1.30 | [Microalbuminuria as a risk factor for diabetic osteopathy in patients with IDDM and renal sufficiency]. ( Goliat, E; Lipińska, A; Marusza, W; Ostrowski, K, 1998) |
| "Hydroxyproline excretion was increased in both types of diabetes: Type 1: 21 (10-36) (median (IQR) mumol mmol creatinine-1; Type 2: 25 (13-43) mumol mmol creatinine-1; control: 10 (6-22) mumol mmol creatinine-1 (p < 0." | 1.29 | Hydroxyproline excretion is increased in diabetes mellitus and related to the presence of microalbuminuria. ( Marshall, SM; Selby, PL; Shearing, PA, 1995) |
| "Therefore the pathogenesis of osteopenia in type 1 DM remains unclear, and requires further investigation." | 1.28 | Study of bone loss in diabetes mellitus type 1. ( Hawkins, F; Larrodera, L; Leon, M; Lledo, G, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (38.89) | 18.7374 |
| 1990's | 9 (50.00) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Black, E | 1 |
| Vibe-Petersen, J | 1 |
| Jorgensen, LN | 1 |
| Madsen, SM | 1 |
| Agren, MS | 1 |
| Holstein, PE | 1 |
| Perrild, H | 1 |
| Gottrup, F | 1 |
| Klujber, L | 1 |
| Szücs, R | 1 |
| Baranyai, Z | 1 |
| Gabulya, J | 1 |
| Soltész, Gy | 1 |
| Tenni, R | 1 |
| Tavella, D | 1 |
| Donnelly, P | 1 |
| Di Ferrante, N | 1 |
| Hill, L | 1 |
| Leach, C | 1 |
| Hatton, D | 1 |
| Selby, PL | 1 |
| Shearing, PA | 1 |
| Marshall, SM | 1 |
| Olmos, JM | 2 |
| Pérez-Castrillón, JL | 1 |
| García, MT | 2 |
| Garrido, JC | 1 |
| Amado, JA | 2 |
| González-Macías, J | 2 |
| Gallacher, SJ | 1 |
| Fenner, JA | 1 |
| Fisher, BM | 1 |
| Quin, JD | 1 |
| Fraser, WD | 1 |
| Logue, FC | 1 |
| Cowan, RA | 1 |
| Boyle, IT | 1 |
| MacCuish, AC | 1 |
| Sayinalp, S | 1 |
| Gedik, O | 1 |
| Koray, Z | 1 |
| Goliat-Marusza, E | 1 |
| Wardyn, K | 1 |
| Stepniewski, M | 1 |
| Marusza, W | 3 |
| Billip-Tomecka, Z | 1 |
| Ostrowski, K | 3 |
| Odetti, P | 1 |
| Traverso, N | 1 |
| Cosso, L | 1 |
| Noberasco, G | 1 |
| Pronzato, MA | 1 |
| Marinari, UM | 1 |
| Goliat, E | 2 |
| Lipińska, A | 2 |
| Zywiec, J | 1 |
| Grzeszczak, W | 1 |
| Pierzchała, K | 1 |
| Błasiak, M | 1 |
| Kuska, J | 1 |
| Kokot, F | 1 |
| Irzyniec, T | 1 |
| Leon, M | 1 |
| Larrodera, L | 1 |
| Lledo, G | 1 |
| Hawkins, F | 1 |
| Mani, I | 1 |
| Mani, UV | 1 |
| el-Kishky, M | 1 |
| Mahfouz, SA | 1 |
| el-Habbak, SM | 1 |
| Goncerzewicz, M | 1 |
| Socha, J | 1 |
| Cichy, W | 1 |
| Nagadowska, J | 1 |
3 trials available for hydroxyproline and Autoimmune Diabetes
| Article | Year |
|---|---|
Bone densitometry and biochemical bone remodeling markers in type 1 diabetes mellitus.
Topics: Acid Phosphatase; Adolescent; Adult; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Density; | 1994 |
[Disorders of bone tissue metabolism in patients in diabetes mellitus type one].
Topics: Adolescent; Adult; Bone Density; Bone Diseases, Metabolic; Calcium; Diabetes Mellitus, Type 1; Femal | 1996 |
[Bone mineralization in insulin-dependent diabetes mellitus].
Topics: Absorptiometry, Photon; Adult; Alkaline Phosphatase; Bone and Bones; Bone Resorption; Calcification, | 1997 |
15 other studies available for hydroxyproline and Autoimmune Diabetes
| Article | Year |
|---|---|
Decrease of collagen deposition in wound repair in type 1 diabetes independent of glycemic control.
Topics: Adult; Aged; Blood Glucose; Case-Control Studies; Collagen; Collagenases; Diabetes Mellitus, Type 1; | 2003 |
Glycosaminoglycan and hydroxyproline excretion in diabetic children.
Topics: Adolescent; Blood Glucose; Child; Child, Preschool; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis | 1982 |
Cultured fibroblasts of juvenile diabetics have excessively soluble pericellular collagen.
Topics: Cell Line; Collagen; Diabetes Mellitus, Type 1; Fibroblasts; Humans; Hydroxyproline; Skin; Solubilit | 1980 |
Hydroxyproline excretion is increased in diabetes mellitus and related to the presence of microalbuminuria.
Topics: Adult; Aged; Albuminuria; Biomarkers; Bone Resorption; Diabetes Mellitus, Type 1; Diabetes Mellitus, | 1995 |
An evaluation of bone density and turnover in premenopausal women with type 1 diabetes mellitus.
Topics: Absorptiometry, Photon; Adult; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Density; Calci | 1993 |
Increasing serum osteocalcin after glycemic control in diabetic men.
Topics: Adult; Alkaline Phosphatase; Blood Glucose; C-Peptide; Calcium; Creatinine; Diabetes Mellitus, Type | 1995 |
Urine hydroxyproline increase in patients with diabetes mellitus.
Topics: Acid Phosphatase; Albuminuria; Alkaline Phosphatase; Biomarkers; Bone Resorption; Diabetes Mellitus, | 1996 |
Good glycaemic control reduces oxidation and glycation end-products in collagen of diabetic rats.
Topics: Abdomen; Aging; Analysis of Variance; Animals; Arginine; Blood Glucose; Body Weight; Collagen; Diabe | 1996 |
[Microalbuminuria as a risk factor for diabetic osteopathy in patients with IDDM and renal sufficiency].
Topics: Absorptiometry, Photon; Adult; Albuminuria; Alkaline Phosphatase; Bone Density; Bone Diseases, Metab | 1998 |
[Bone complication in diabetes subjects with good metabolic control and without longterm complications: certain problems. Part II. Basal parameters of bone turnover].
Topics: Alkaline Phosphatase; Bone Resorption; Creatine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type | 2001 |
[Selected indicators of calcium-phosphate metabolism in patients with diabetes mellitus].
Topics: Adult; Calcium; Circadian Rhythm; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Huma | 1989 |
Study of bone loss in diabetes mellitus type 1.
Topics: Alkaline Phosphatase; Blood Glucose; Blood Proteins; Bone and Bones; Bone Diseases, Metabolic; Bone | 1989 |
Urinary excretion of hydroxyproline in diabetics under different modes of treatment.
Topics: Adult; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Hydroxyproline; Hypogly | 1986 |
An in vitro study of hydroxyproline synthesis by gingival fibroblasts in patients with juvenile diabetes.
Topics: Adolescent; Adult; Diabetes Mellitus, Type 1; Fibroblasts; Gingiva; Humans; Hydroxyproline; Male | 1986 |
[Hydroxyproline indicators in the evaluation of nutritional status of children with various metabolic diseases].
Topics: Child; Child Nutrition Disorders; Diabetes Mellitus, Type 1; Endocrine System Diseases; Female; Huma | 1974 |